Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
暂无分享,去创建一个
G. Semenza | A. Höke | S. Keswani | M. Bosch-Marcé | N. Reed | A. Fischer | M. Bosch‐Marcé | M. Bosch-Marce | Sanjay C. Keswani
[1] J. McArthur,et al. Schwann cell chemokine receptors mediate HIV‐1 gp120 toxicity to sensory neurons , 2003, Annals of neurology.
[2] A. Hoffmann,et al. Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. , 2010, Genes & development.
[3] P. Ghezzi,et al. Erythropoietin both protects from and reverses experimental diabetic neuropathy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Epstein,et al. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. , 2010, Blood.
[5] D. Kleinfeld,et al. The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. , 2009, The Journal of clinical investigation.
[6] P. Lewczuk,et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Hoke,et al. Erythropoietin is neuroprotective in models of HIV sensory neuropathy , 2004, Neuroscience Letters.
[8] M. Gassmann,et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. , 1998, Genes & development.
[9] J. Merrill,et al. The role of nitric oxide in multiple sclerosis , 1997, Journal of Molecular Medicine.
[10] A. Höke,et al. Neuroprotection in the PNS: erythropoietin and immunophilin ligands. , 2005, Annals of the New York Academy of Sciences.
[11] D. Price,et al. Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[12] Stuart A. Lipton,et al. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.
[13] T. Dawson,et al. Deadly Conversations: Nuclear-Mitochondrial Cross-Talk , 2004, Journal of bioenergetics and biomembranes.
[14] A. Hoke,et al. FK506 is neuroprotective in a model of antiretroviral toxic neuropathy , 2003, Annals of neurology.
[15] U. Dirnagl,et al. Hypoxia-Induced Stroke Tolerance in the Mouse Is Mediated by Erythropoietin , 2003, Stroke.
[16] U. Dirnagl,et al. Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an In Vitro Model , 2002, The Journal of Neuroscience.
[17] G. Semenza,et al. Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia‐Reperfusion Injury , 2003, Circulation.
[18] Majid Ali. Oxygen Homeostasis , 2005 .
[19] T. Honda,et al. Nitric oxide synthase expressions in rat dorsal root ganglion after a hind limb tourniquet , 2003, Neuroreport.
[20] G. Semenza,et al. Induction of hypoxia‐inducible factor‐1 (HIF‐1) and its target genes following focal ischaemia in rat brain , 1999, The European journal of neuroscience.
[21] John T. Finn,et al. Axonal Self-Destruction and Neurodegeneration , 2002, Science.
[22] R. Lehmann,et al. Hypoxia-Inducible Factor-1 Is Central to Cardioprotection: A New Paradigm for Ischemic Preconditioning , 2008, Circulation.
[23] G. Semenza,et al. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. , 1993, Blood.
[24] J. Barnes,et al. Peripheral Neuropathy in Rats Produced by Acrylamide , 1966, British journal of industrial medicine.
[25] Kenneth Maiese,et al. Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases , 2002, Circulation.
[26] P. Narasimhan,et al. Neuroprotection by Hypoxic Preconditioning Involves Oxidative Stress-Mediated Expression of Hypoxia-Inducible Factor and Erythropoietin , 2005, Stroke.
[27] G. Semenza,et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[28] E. Lehning,et al. Acrylamide-induced distal axon degeneration: a proposed mechanism of action. , 1994, Neurotoxicology.
[29] G. Semenza,et al. Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin , 1999, The Journal of Neuroscience.
[30] Kiichi Hirota,et al. Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1 , 2003, Circulation research.
[31] W. Kaelin,et al. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.
[32] K. Boje. Nitric oxide neurotoxicity in neurodegenerative diseases. , 2004, Frontiers in bioscience : a journal and virtual library.
[33] R. Myers,et al. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] G. Semenza,et al. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. , 2008, Cardiovascular research.
[35] M. Raff,et al. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve , 1979, Brain Research.
[36] R. Ratan,et al. Translation of Ischemic Preconditioning to the Patient: Prolyl Hydroxylase Inhibition and Hypoxia Inducible Factor-1 as Novel Targets for Stroke Therapy , 2004, Stroke.
[37] T. Beaty,et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. , 1999, The Journal of clinical investigation.
[38] A. Cerami,et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Fandrey,et al. Oxygen-sensing under the influence of nitric oxide. , 2010, Cellular signalling.
[40] A. Hoke,et al. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration , 2004, Annals of neurology.